Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 7
2004 4
2005 9
2006 2
2007 4
2008 5
2009 5
2010 5
2011 6
2012 5
2013 4
2014 6
2015 5
2016 3
2017 5
2018 6
2019 7
2020 11
2021 14
2022 8
2023 9
2024 8
2025 7
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean stefani vittorio (23 results)?
Dissecting minimal residual disease dynamics to improve outcome prediction in mantle cell lymphoma: Data from the Fondazione Italiana Linfomi (FIL)-MCL0208 clinical trial.
Cordero F, Ferrero S, Pernice S, Genuardi E, Volpatto D, Sirovich R, Civita AM, Evangelista A, Ragaini S, Di Rocco A, Re A, Stefoni V, Cavallo F, Boccomini C, Balzarotti M, Zilioli VR, Gomes da Silva M, Arcaini L, Celli M, Zaccaria GM, Tortarolo D, Beccuti M, Hoster E, Pott C, Macintyre E, Hermine O, Dreyling M, Ladetto M. Cordero F, et al. Among authors: stefoni v. Hemasphere. 2026 Apr 30;10:e70375. doi: 10.1002/hem3.70375. eCollection 2026 May. Hemasphere. 2026. PMID: 42079742 Free PMC article.
Clinical impact of immunoglobulin heavy chain repertoire in mantle cell lymphoma: A study from the Fondazione Italiana Linfomi (FIL) Phase III MCL0208 trial.
Ragaini S, Genuardi E, Alessandria B, Civita AM, Evangelista A, Drandi D, Montana C, Russo S, Consoli C, Pironti M, Hohaus S, Musuraca G, Cascavilla N, Ghiggi C, Tani M, Gaidano G, Olivieri J, Usai SV, Di Renzo N, Luppi M, Stefoni V, Cavallo F, Ladetto M, Ferrero S. Ragaini S, et al. Among authors: stefoni v. Hemasphere. 2026 Jan 20;10(1):e70285. doi: 10.1002/hem3.70285. eCollection 2026 Jan. Hemasphere. 2026. PMID: 41568240 Free PMC article. No abstract available.
SARS-CoV-2 infection does not affect the outcome of patients with relapsed/refractory large B-cell lymphoma treated with CAR T-cell therapy.
Gentilini M, Casadei B, Pellegrini C, Argnani L, Gugliotta G, Carella M, Stefoni V, Fabbri N, Gabrielli G, Salvatore F, Desiderio A, Mazzoni C, Maglio P, Bagnato G, Broccoli A, Bonifazi F, Zinzani PL. Gentilini M, et al. Among authors: stefoni v. Ann Hematol. 2025 Jun;104(6):3319-3331. doi: 10.1007/s00277-025-06425-8. Epub 2025 Jun 4. Ann Hematol. 2025. PMID: 40464897 Free PMC article.
Long-term results of the FIL MCL0208 trial of lenalidomide maintenance versus observation after ASCT in MCL patients.
Tavarozzi R, Ferrero S, Evangelista A, Genuardi E, Drandi D, Mian M, Zanni M, Cavallo F, Di Rocco A, Stefoni V, Pagani C, Re A, Botto B, Balzarotti M, Zilioli VR, da Silva MG, Arcaini L, Molinari AL, Ballerini F, Ferreri AJM, Puccini B, Visco C, Stefani PM, Luppi M, Casaroli I, Stelitano C, Ciccone G, Vitolo U, Martelli M, Cortelazzo S, Ladetto M. Tavarozzi R, et al. Among authors: stefoni v. Hemasphere. 2025 Mar 22;9(3):e70102. doi: 10.1002/hem3.70102. eCollection 2025 Mar. Hemasphere. 2025. PMID: 40124719 Free PMC article. No abstract available.
Further strategies after immune checkpoint inhibitors in relapsed/refractory Hodgkin lymphoma: salvage treatments and consolidation with transplantation, experience in daily clinical practice.
Pellegrini C, Casadei B, Broccoli A, Cantelli M, Gugliotta G, Gentilini M, Carella M, Stefoni V, Fabbri N, Gabrielli G, Argnani L, Mazzoni C, Maglio P, Bagnato G, Zinzani PL. Pellegrini C, et al. Among authors: stefoni v. Ann Hematol. 2025 Mar;104(3):1757-1764. doi: 10.1007/s00277-025-06255-8. Epub 2025 Mar 1. Ann Hematol. 2025. PMID: 40025210 Free PMC article.
Long-term efficacy of immune checkpoint inhibitors for relapsed primary mediastinal B-cell lymphoma: a real-world study.
Casadei B, Argnani L, Broccoli A, Cantelli M, Gugliotta G, Gentilini M, Carella M, Stefoni V, Pellegrini C, Fabbri N, Gabrielli G, Mazzoni C, Maglio P, Bagnato G, Zinzani PL. Casadei B, et al. Among authors: stefoni v. Blood Adv. 2025 May 13;9(9):2044-2047. doi: 10.1182/bloodadvances.2024015581. Blood Adv. 2025. PMID: 39993241 Free PMC article. No abstract available.
Large clones of clonal hematopoiesis affect outcome in mantle cell lymphoma: results from the FIL MCL0208 clinical trial.
Ragaini S, Galli A, Genuardi E, Gandossini M, Alessandria B, Civita AM, Evangelista A, Amaducci E, Stefoni V, Cavallo F, Ballerini F, Puccini B, Vallisa D, Michieli M, Pascarella A, Palmas A, Patti C, Lucchini E, Careddu MG, Merli M, Postorino M, Boccomini C, Balzarotti M, Zilioli VR, Gomes da Silva M, Bruno B, Rizzo E, Ladetto M, Malcovati L, Ferrero S. Ragaini S, et al. Among authors: stefoni v. Blood Adv. 2025 Apr 22;9(8):1805-1815. doi: 10.1182/bloodadvances.2024014948. Blood Adv. 2025. PMID: 39808795 Free PMC article. Clinical Trial.
129 results